9 天前 - … Passive immunotherapies—available from the first convalescent … of COVID-19,
and the pipeline for pandemic candidates. … The COVID-19 pandemic has represented an …

10 天前 - … resemblance to the coronavirus associated with severe … COVID-19 have been
published by researchers. The main type of biotherapeutics used in passive immunotherapy to …

10 天前 - … This study showed the outcomes of six hospitalised patients with COVID-19 pneumonia
… shelf” NK cell infusion from a convalescent COVID-19 donor. This study was a phase I …

11 天前 - … onset of SFN after COVID-19 infection and vaccination, … phenotypes or response
to immunotherapy remains to be … immunotherapy and their role in the development of iSFN. …

14 天前 - … He also oversaw the journal during the tumultuous period of COVID-19. This period
witnessed … brought enormous resources to bear on the COVID pandemic. During this time, …

16 天前 - … Convalescent plasma (CP) therapy is a classic adaptive immunotherapy that has
been applied in the prevention and treatment of infectious diseases for more than a century …

17 天前 - … management of COVID-19 pneumonia in lung cancer patients, especially those
who received immunotherapy or thoracic radiotherapy (TRT). Immunotherapy represented by …

18 天前 - … We will examine the role of mRNA vaccines in the global response to the COVID-19
pandemic, as well as their potential in cancer immunotherapy, genetic disorder treatments, …

19 天前 - … the application of new forms of immunotherapy. NK cells can … The situation involving
NK cells during the COVID-19 … of patients su®ering from both COVID-19 and cancer13; our …

19 天前 - … a severe disease that emerged during the COVID-19 pandemic. Although recognized
as an … Furthermore, the absence of a diagnostic test can lead to delayed immunotherapy. …